In this episode of the Chase MedSearch Podcast, Jordan Chase sits down with Peter Calabrese — Senior Digital Product Program Manager and longtime neuromodulation leader—to unpack how digital ecosystems, data interoperability, and AI are transforming deep brain and spinal cord stimulation.

Peter shares how the next era of neuromodulation will be defined not only by implantable devices, but by the data they generate—and how that data improves outcomes from the PACU to long-term follow-up. He explains the emerging shift toward software-as-a-subscription in MedTech, the growing expectations from payers for interoperability, and why companies are racing to build secure, scalable data “lakes” before deploying front-facing AI tools.

Peter also takes us through his personal career arc: 15 years as a high-performing field rep, his fascination with solving complex problems, and the transition to in-house marketing and product development. He shares the real profile of a Medical Device Sales Rep. who should consider this path—and what the first week in marketing feels like after years in the operating room (OR).

Whether you're a medical device rep, sales leader, or someone tracking the digital shift in MedTech, this episode delivers key insights into where neuromodulation is going next—and how sales professionals can prepare for the future.

RESOURCES

Biodesign Courses Recommended by Peter Calabrese: https://med.stanford.edu/biodesign/programs/stanford-courses.html

🎧 Love what you hear? Share this episode with a friend and subscribe to the podcast! / @chasemedsearchpodcast

📄 Looking for your next role in medical device? We’d love to connect with you! Send us your resume and let’s get started!

From Devices to Data: The Future of Neuromodulation with Peter Calabrese